Q4 2021 Holdings
Filed 2022-02-14 | 71 holdings | $333.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc.(IDYA) | COM | 45166A102 | $52.1K | 2,202,812 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $54.3K | 507,374 | 0.0% |
| Merus NV | COM | N5749R100 | $60.4K | 1,900,000 | 0.0% |
| Spdr SER TRCall | Call | 78464A900 | $61.6K | 550,000 | 0.0% |
| PMV Pharmaceuticals Inc.(PMVP) | COM | 69353Y103 | $65.6K | 2,838,236 | 0.0% |
| Tango Therapeutics inc(TNGX) | COM | 87583X109 | $75.2K | 6,871,642 | 0.0% |
| Relay Therapeutics Inc.(RLAY) | COM | 75943R102 | $82.0K | 2,669,132 | 0.0% |
| Revolution Medicines Inc.(RVMD) | COM | 76155X100 | $87.7K | 3,484,264 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $90.7K | 6,448,359 | 0.0% |
| Springworks Therapeutics Inc. | COM | 85205L107 | $128.7K | 2,075,905 | 0.0% |
| iTeos Therapeutics Inc.(5E7) | COM | 46565G104 | $202.3K | 4,345,016 | 0.1% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $246.3K | 2,200,000 | 0.1% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $293.4K | 2,000,000 | 0.1% |
| Cabaletta Bio Inc.(CABA) | COM | 12674W109 | $2.0M | 540,000 | 0.6% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $4.3M | 185,000 | 1.3% |
| Biomea Fusion Inc.(BMEA) | COM | 09077A106 | $8.9M | 1,188,405 | 2.7% |
| Black Diamond Therapeutics Inc.(BDTX) | COM | 09203E105 | $10.7M | 2,014,858 | 3.2% |
| Cullinan Oncology Inc.(CGEM) | COM | 230031106 | $16.6M | 1,074,082 | 5.0% |
| Arcus Biosciences Inc.(RCUS) | COM | 03969F109 | $58.0M | 1,432,200 | 17.4% |
| Cytokinetics Inc.(CYTK) | COM NEW | 23282W605 | $95.7M | 2,100,000 | 28.7% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $135.5M | 500,000 | 40.6% |